The Mass Dynamics Blog

Notes from the lab, the platform, and the field.

Scientific deep dives, product thinking, and perspectives on proteomics, reproducibility, and agent-ready science — from the team building Mass Dynamics.

Thoughts

An entrepreneurial mindset doesn't require starting a company. Five founders explained why.

The room was mostly PhD students, postdocs, facility managers, and scientists. People who may or may not have started a company but were ...

Paula Burton Mar 24, 2026
Thoughts

Proteomics is working - the real challenge is coordination

It wasn’t a trade show or a marketing showcase. The room was intimate - directors, VPs, heads of platform, chemists, bioinformaticians. The ...

Paula Burton Feb 25, 2026
Thoughts

Why proteomics needs harder conversations (and more of them)

Proteomics is at an inflection point. Not one that will be resolved by faster instruments, cheaper compute, or another exponential curve on ...

Paula Burton Jan 29, 2026
Thoughts

It’s not a data problem, it’s a decision problem: 5 tips from Boston’s proteomics leaders

Why We Ran CONNECT: Boston

A/Prof Andrew Webb, Ph.D Dec 10, 2025
Thoughts

Stop Rolling the Dice: Why Proteomics Needs to Move Upstream in Drug Development

Discovery

A/Prof Andrew Webb, Ph.D Aug 19, 2025
Thoughts

From Lab Bench to Boardroom: Proteomics Comes of Age

Core fishbowl panelists and facilitators (left to right): Paula Burton, Chiara Guerrera, Harris Bell-Temin, Olga Vitek, Joey Latham, Andrew ...

A/Prof Andrew Webb, Ph.D Jun 26, 2025
Thoughts

Unlock Hidden Value: Integrate Proteomics and Drive Biology’s Next Leap

I’ve spent nearly two decades navigating the tsunami of data - first as an academic proteomics lead, now as a founder building platforms to ...

A/Prof Andrew Webb, Ph.D Apr 29, 2025
Thoughts

Proteomics at a Crossroads: Why We Must Rethink Data Analysis

Proteomics is accelerating. Can our current tools keep up?

A/Prof Andrew Webb, Ph.D Feb 28, 2025
Thoughts

Pioneering Multivariate Companion Markers: Collaborative Pathways to Accelerate Market Access

Introduction: The Urgency of Multivariate Companion Markers in Precision Medicine

Paula Burton Feb 6, 2025
Thoughts

Transforming Drug Discovery: The Critical Role of Proteomics and Targeted Protein Degradation in the Future of Therapeutics

Introduction: A Paradigm Shift in Drug Discovery

A/Prof Andrew Webb, Ph.D Oct 15, 2024
Thoughts

Coffees, conversations, and negotiations: an energizing day @ FeMS “Out Of The Shadows” Workshop

Dr Anna Quaglieri, Ph.D Aug 28, 2024